Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) For The Treatment Of Fabry Disease
Amicus Therapeutics (Nasdaq: FOLD) announced it has commenced the U.S. registration Phase 3 trial with its investigational drug, Amigal(TM) (migalastat hydrochloride) for the treatment of Fabry disease. The Company has reached agreement with the U.S. Food and Drug Administration (FDA) on the key protocol design elements of the pivotal trial, including the use of the surrogate primary endpoint of the change in the amount of kidney interstitial capillary GL-3, the substrate that accumulates in the cells of Fabry patients. In addition, the FDA is in agreement that the Company is eligible to seek Accelerated Approval for Amigal according to Subpart H regulations. The Company has begun submitting the Phase 3 protocol to investigational sites worldwide and expects to begin the dosing of subjects in the second half of this year.
generic viagra online
Symposium & Live Announcement Of Genetics And Neuroscience Prize Recipients: Gruber Prize Program 10th Anniversary
July 1, 2009
News of the day
Continuing VA Endoscope Contamination Problem Unacceptable, Says The American Legion
The national commander of the nation"s largest veterans service organization is expressing outrage at continuing instances of VA medical personnel exposing their patients to infectious diseases.
Endocrinology

318 Articles On The H1N1 Swine Flu Virus Available Online Free Of Charge On SpringerLink

Springer Science+Business Media is offering all journal articles which deal with the H1N1 virus, or swine flu, free of charge on its online information platform http://www.springerlink.com. The articles can be found by using the search term "H1N1." A total of 318 scientific articles will be available to print out or download from now until 31 December 2009. In June 2009, the World Health Organization raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the H1N1 virus. A Phase 6 designation indicates that a global pandemic is underway. More than 70 countries are now reporting cases of human infection with H1N1 flu. Eric Merkel-Sobotta, Executive Vice President Corporate Communications of Springer Science+Business Media, said, "As a global scientific, technical and medical publisher, Springer plays a major role in the distribution of scientific information and access to knowledge and research. Therefore we are making all studies, published up to now on the H1N1 virus, freely available online on SpringerLink. By doing this, we hope to push forward scientific research on the causes, cures and other facets of this virus." Renate Bayaz Springer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009